Clinical Trial Update: ACE1831 in Adult Subjects With Relapsed/Refractory Systemic Lupus Erythematosus （SLE） [NA]

View source ↗

Summary

ACE1831 is being studied in adults with relapsed/refractory systemic lupus erythematosus; this Tongji Hospital-sponsored trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• ACE1831

Snippet

Sponsor: Tongji Hospital | Conditions: System Lupus Erythematosus(SLE) | NA | Status: NOT_YET_RECRUITING